Sign In
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- US Share Prices
- Stock Tips
- Share Chat
- FX
- News & RNS
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Angle Share News (AGL)
AGL Share
Price
AGL Share
News
AGL Share
Chat
AGL Share
Trades37
AGL
Live RNS
AGL Share
Charts
AGL Broker
Ratings
AGL Directors
Deals
AGL Financial
Diary
AGL
Fundamentals
AGL Short
Positions
AGL
Media
AGL Company
Research
AGL Company
Timeline
- There is currently no data for AGL
IN BRIEF: Angle highlights supportive data for DNA analysis tool
Angle PLC - Surrey-based medical diagnostics provider - Announces publication of a peer-reviewed paper in a special issue of the journal - "Current Issues in Molecular Biology" Special Issue: Advanced Solutions for Cancer Therapy. Article brings together supporting evidence for the additional and complementary information that can be obtained from circulating tumour cells, demonstrating the value of a dual analyte approach for both CTCs and ctDNA (fragments of DNA released mainly by dying cells). Angle recently announced breakthrough data for real-time parallel next generation sequencing DNA analysis of both ctDNA and CTCs from a single tube of patient blood, using a pan-cancer panel run on an Illumina NGS system.
Current stock price: 17.85 pence, down 8.5% in London on Monday
12-month change: down 42%
By Jeremy Cutler, Alliance News reporter
Comments and questions to newsroom@alliancenews.com
Copyright 2024 Alliance News Ltd. All Rights Reserved.
Latest AGL News
- UK EARNINGS SUMMARY: Gfinity Continues Review Including Possible Sale
29 Oct 2020 - UPDATE: Angle Successfully Raises GBP20 Million In Placing
27 Oct 2020 - IN BRIEF: Angle To Raise GBP20 Million To Fund Operations
27 Oct 2020 - UK Earnings, Trading Statements Calendar - Next 7 Days
22 Oct 2020 - IN BRIEF: Angle Says FDA Accepts Parsotix Submission For Breast Cancer
20 Oct 2020 - FDA accepts Angle's review submission for Parsortix PC1
20 Oct 2020 - IN BRIEF: Angle Submits US FDA De Novo Application For Parsortix
28 Sep 2020 - UK Shareholder Meetings Calendar - Next 7 Days
20 Aug 2020
Related News
IN BRIEF: Angle names Peter Collins as interim CEO
(Alliance News) - Angle PLC - Guildford, England-based liquid biopsy company, which is to be renamed CelLBxHealth PLC - Appoints Peter Collins as inte...
Angle touts planned name and strategy change, Groen turns executive
(Alliance News) - Angle PLC shares fell on Wednesday, after it announced plans to rename itself CelLBxHealth PLC and "[pursue] a revised strategy", wi...
IN BRIEF: Angle CEO and finance lead step down after shareholder talks
Angle PLC - Guildford, England-based liquid biopsy company - Says that, following talks with an unnamed "significant shareholder", Chief Executive Off...
Angle News
UK EARNINGS SUMMARY: Gfinity Continues Review Including Possible Sale
UK EARNINGS SUMMARY: Gfinity Continues Review Including Possible Sale
UPDATE: Angle Successfully Raises GBP20 Million In Placing
UPDATE: Angle Successfully Raises GBP20 Million In Placing
IN BRIEF: Angle To Raise GBP20 Million To Fund Operations
IN BRIEF: Angle To Raise GBP20 Million To Fund Operations
UK Earnings, Trading Statements Calendar - Next 7 Days
UK Earnings, Trading Statements Calendar - Next 7 Days
IN BRIEF: Angle Says FDA Accepts Parsotix Submission For Breast Cancer
IN BRIEF: Angle Says FDA Accepts Parsotix Submission For Breast Cancer
FDA accepts Angle's review submission for Parsortix PC1
(Sharecast News) - Liquid biopsy company Angle announced on Tuesday that the US Food and Drug Administration (FDA) has completed its administrative re...
IN BRIEF: Angle Submits US FDA De Novo Application For Parsortix
IN BRIEF: Angle Submits US FDA De Novo Application For Parsortix
UK Shareholder Meetings Calendar - Next 7 Days
UK Shareholder Meetings Calendar - Next 7 Days
Follow the stocks
